ADVERTISEMENT FEATURE NATUREJOBS SPOTLIGHT ON

GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH A centre for stem cell and translational medicine in the Pearl River Delta

Just over a decade old, the Guangzhou conviction, GIBH is devoting resources discovery. It is actively seeking external col- Institutes of Biomedicine and Health is to developing cutting-edge technologies laborations and partnerships with scien- exploring new ways to combat disease and to solving important scientific prob- tists and institutes where there is a mutual through conducting vital research. lems in a collaborative environment. interest. GIBH offers commitment, creativ- Accordingly, GIBH is building a new state- ity and opportunity. GIBH seeks individuals he Guangzhou Institutes of of-the-art good-manufacturing-practice who share its vision and enthusiasm for the Biomedicine and Health (GIBH), facility to manufacture clinical-grade future. Positions are available at all ranks Chinese Academy of Sciences, cells, including neural stem cells and in five research programmes (for more in- Twas established in 2003 by the Chinese hepatocyte progenitor cells for human formation, visit http://www.gibh.cas.cn or Academy of Sciences, through collabora- transplantation; these cells will be used http://english.gibh.cas.cn): tive agreements with the and to treat diseases of the central nervous Guangzhou governments. The founders system and liver, respectively. • Stem cell and regenerative medicine envisioned a modern institute with a • Chemistry and synthetic biology forward-looking philosophy that would Drug discovery • Infection and immunity transform the research landscape of south- Over the years, GIBH has established a • Public health ern . GIBH is realizing that vision, as solid reputation through high-profile • Drug discovery pipeline evidenced by its gaining global recognition publications and the development of of its cutting-edge scientific research. innovative drugs. For example, its in- novative drug-discovery platform has Strategic research advanced a number of clinical candidate GIBH has become a first-rate organization drugs for the treatment of cancer and with over 500 dedicated staff members neural degenerative diseases. Two of its and more than 300 graduate students. investigational new drugs were recently The scientists and students are currently certified in 2016 by the Chinese Food engaging in five major fields of inquiry: and Drug Administration, allowing for the stem cell biology, chemical biology, initiation of phase-one clinical trials in infection and immunity, public health China. Its dual focus on original discovery and de novo drug discovery. The GIBH and innovative applications will propel Contact 2016 12 MAY strategy combines both basic and trans- the organization towards even greater lational research in focused areas. This achievements in years to come. E-mail: [email protected] strategy will not only provide a deep un- Tel: 0086-20-32015342, 32015267 derstanding of life and disease, but also Seeking collaborators Fax: 0086-20-32015267 catalyze breakthroughs in the diagnosis The overall vision of GIBH is to serve the Address: 190 Kaiyuan Avenue, Science and treatment of illnesses. Based on this citizens of China and the world through Park, Guangzhou, China, 510530 | NATUREJOBS | | NATUREJOBS 3 Advertiser retains sole responsibility for content